Hydroxychloroquine ‘Significantly’ Reduces Death Rate From CCP-virus, Detroit area study shows


Anti-malaria drug hydroxychloroquine helps the lower the death rate of CCP-virus patients according to a study in the Detroit area conducted by Henry Ford Health System.


Due to a lack of effective alternatives, Chinese and Indian doctors at the frontline fighting the CCP-virus also take hydroxychloroquine to prevent infections.

But it is worth noting that there are studies against the use of hydroxychloroquine for patients in critical condition combined with a high dosage of the drug. But the effective way to use this drug is a low dosage for patients with early symptoms.

June 30: UK Resumes trials on hydroxychloroquine

Inline Feedbacks
View all comments